CancerNetwork·
Targeting KRAS in Pancreatic Cancer: What is Daraxonrasib’s Mechanism of Action?

Asfar Azmi, PhD, discusses the tricomplex mechanism of daraxonrasib and its impact on overall survival for patients with pancreatic cancer.
You are reading a snippet
Read the full article on CancerNetwork
Originally published by CancerNetwork


